Noninvasive methods to assess liver disease in patients with hepatitis B or C

Gastroenterology

Volumn 142, Issue 6, 2012, Pages

  Castera, Laurent ^a  

^a BEAUJON HOSPITAL   (France)

Author keywords

Diagnostic Test; Therapy; Treatment; Virology

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; ASPARTATE AMINOTRANSFERASE; HEPATITIS E ANTIGEN; INTERFERON;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DISEASE COURSE; ELASTOGRAPHY; FALSE POSITIVE RESULT; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER PARENCHYMA; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84860299294     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.02.017     Document Type: Article

References (159)

1. EASL clinical practice guidelines: management of chronic hepatitis B J Hepatol 50 2009 227 242
2. A.S. Lok, B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
3. M.G. Ghany, D.B. Strader, D.L. Thomas Diagnosis, management, and treatment of hepatitis C: an update Hepatology 49 2009 1335 1374
4. M.G. Ghany, D.R. Nelson, D.B. Strader An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases Hepatology 54 2011 1433 1444
5. EASL clinical practice guidelines: management of hepatitis C virus infection J Hepatol 55 2011 245 264
6. A.A. Bravo, S.G. Sheth, S. Chopra Liver biopsy N Engl J Med 344 2001 495 500
7. K. Ishak, A. Baptista, L. Bianchi Histological grading and staging of chronic hepatitis J Hepatol 22 1995 696 699
8. P. Bedossa, T. Poynard The METAVIR cooperative study group An algorithm for the grading of activity in chronic hepatitis C Hepatology 24 1996 289 293
9. B. Maharaj, R.J. Maharaj, W.P. Leary Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver Lancet 1 1986 523 525
10. A. Regev, M. Berho, L.J. Jeffers Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection Am J Gastroenterol 97 2002 2614 2618
11. D.C. Rockey, S.H. Caldwell, Z.D. Goodman Liver biopsy Hepatology 49 2009 1017 1044
12. L. Castera, M. Pinzani Noninvasive assessment of liver fibrosis: are we ready? Lancet 375 2010 1419 1420
13. S.H. Mehta, B. Lau, N.H. Afdhal Exceeding the limits of liver histology markers J Hepatol 50 2009 36 41
14. D.F. Ransohoff, A.R. Feinstein Problems of spectrum and bias in evaluating the efficacy of diagnostic tests N Engl J Med 299 1978 926 930
15. T. Poynard, P. Halfon, L. Castera Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages Clin Chem 53 2007 1615 1622
16. G. Sebastiani, L. Castera, P. Halfon The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases Aliment Pharmacol Ther 34 2011 1202 1216
17. N.A. Obuchowski An ROC-type measure of diagnostic accuracy when the gold standard is continuous-scale Stat Med 25 2006 481 493
18. M. Pinzani, F. Vizzutti, U. Arena Technology insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography Nat Clin Pract Gastroenterol Hepatol 5 2008 95 106
19. D.S. Manning, N.H. Afdhal Diagnosis and quantitation of fibrosis Gastroenterology 134 2008 1670 1681
20. L. Castera Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis J Viral Hepat 16 2009 300 314
21. F. Imbert-Bismut, V. Ratziu, L. Pieroni Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Lancet 357 2001 1069 1075
22. X. Forns, S. Ampurdanes, J.M. Llovet Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model Hepatology 36 2002 986 992
23. C.T. Wai, J.K. Greenson, R.J. Fontana A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C Hepatology 38 2003 518 526
24. K. Patel, S.C. Gordon, I. Jacobson Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients J Hepatol 41 2004 935 942
25. V. Leroy, F. Monier, S. Bottari Circulating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid Am J Gastroenterol 99 2004 271 279
26. W.M. Rosenberg, M. Voelker, R. Thiel Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 2004 1704 1713
27. A. Sud, J.M. Hui, G.C. Farrell Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index Hepatology 39 2004 1239 1247
28. L.A. Adams, M. Bulsara, E. Rossi Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection Clin Chem 51 2005 1867 1873
29. P. Cales, F. Oberti, S. Michalak A novel panel of blood markers to assess the degree of liver fibrosis Hepatology 42 2005 1373 1381
30. A.S. Lok, M.G. Ghany, Z.D. Goodman Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort Hepatology 42 2005 282 292
31. S. Islam, L. Antonsson, J. Westin Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers Scand J Gastroenterol 40 2005 867 872
32. A.Y. Hui, H.L. Chan, V.W. Wong Identification of chronic hepatitis B patients without significant liver fibrosis by a simple noninvasive predictive model Am J Gastroenterol 100 2005 616 623
33. M.D. Zeng, L.G. Lu, Y.M. Mao Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model Hepatology 42 2005 1437 1445
34. R.J. Fontana, D.E. Kleiner, R. Bilonick Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection Hepatology 44 2006 925 935
35. M. Koda, Y. Matunaga, M. Kawakami FibroIndex, a practical index for predicting significant fibrosis in patients with chronic hepatitis C Hepatology 45 2007 297 306
36. A. Vallet-Pichard, V. Mallet, B. Nalpas FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection Comparison with liver biopsy and Fibrotest Hepatology 46 2007 32 36
37. R.J. Fontana, Z.D. Goodman, J.L. Dienstag Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C Hepatology 47 2008 789 798
38. P. Cales, P. Veillon, A. Konate Reproducibility of blood tests of liver fibrosis in clinical practice Clin Biochem 41 2008 10 18
39. F. Imbert-Bismut, D. Messous, V. Thibaut Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors Clin Chem Lab Med 42 2004 323 333
40. T. Poynard, M. Munteanu, F. Imbert-Bismut Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C Clin Chem 10 2004 10
41. L. Sandrin, B. Fourquet, J.M. Hasquenoph Transient elastography: a new noninvasive method for assessment of hepatic fibrosis Ultrasound Med Biol 29 2003 1705 1713
42. D. Roulot, S. Czernichow, H. Le Clesiau Liver stiffness values in apparently healthy subjects: influence of gender and metabolic syndrome J Hepatol 48 2008 606 613
43. S.U. Kim, G.H. Choi, W.K. Han What are "true normal" liver stiffness values using FibroScan? A prospective study in healthy living liver and kidney donors in South Korea Liver Int 30 2010 268 274
44. S. Colombo, L. Belloli, M. Zaccanelli Normal liver stiffness and its determinants in healthy blood donors Dig Liver Dis 43 2011 231 236
45. D. Lucidarme, J. Foucher, B. Le Bail Factors of accuracy of transient elastography (Fibroscan) for the diagnosis of liver Fibrosis in chronic hepatitis C Hepatology 2009 1083 1089
46. R.P. Myers, P. Crotty, G. Pomier-Layrargues Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy Liver Int 30 2010 1471 1480
47. L. Castera, X. Forns, A. Alberti Non-invasive evaluation of liver fibrosis using transient elastography J Hepatol 48 2008 835 847
48. M. Fraquelli, C. Rigamonti, G. Casazza Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease Gut 56 2007 968 973
49. J. Boursier, A. Konate, G. Gorea Reproducibility of liver stiffness measurement by ultrasonographic elastometry Clin Gastroenterol Hepatol 6 2008 1263 1269
50. L. Castera, J. Foucher, P.H. Bernard Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations Hepatology 51 2010 828 835
51. R.P. Myers, G. Pomier-Layrargues, R. Kirsch Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients Hepatology 55 2012 199 208
52. L. Castera, M. Pinzani Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59 2010 861 866
53. U. Arena, F. Vizzutti, J.G. Abraldes Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C Gut 57 2008 1288 1293
54. M. Fraquelli, C. Rigamonti, G. Casazza Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C J Hepatol 54 2011 621 628
55. K. Nightingale, M.S. Soo, R. Nightingale Acoustic radiation force impulse imaging: in vivo demonstration of clinical feasibility Ultrasound Med Biol 28 2002 227 235
56. R. Muthupillai, D.J. Lomas, P.J. Rossman Magnetic resonance elastography by direct visualization of propagating acoustic strain waves Science 269 1995 1854 1857
57. J.A. Talwalkar, M. Yin, J.L. Fidler Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications Hepatology 47 2008 332 342
58. T. Poynard, R. Morra, P. Halfon Meta-analyses of Fibrotest diagnostic value in chronic liver disease BMC Gastroenterol 7 2007 40
59. Z.H. Lin, Y.N. Xin, Q.J. Dong Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis Hepatology 53 2011 726 736
60. J. Parkes, I.N. Guha, P. Roderick Performance of serum marker panels for liver fibrosis in chronic hepatitis C J Hepatol 44 2006 462 474
61. P. Halfon, Y. Bacq, A. De Muret Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C J Hepatol 46 2007 395 402
62. V. Leroy, M.N. Hilleret, N. Sturm Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C J Hepatol 46 2007 775 782
63. P. Cales, V. de Ledinghen, P. Halfon Evaluating the accuracy and increasing the reliable diagnosis rate of blood tests for liver fibrosis in chronic hepatitis C Liver Int 28 2008 1352 1362
64. F. Degos, P. Perez, B. Roche Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study) J Hepatol 53 2010 1013 1021
65. J.P. Zarski, N. Sturm, J. Guechot Comparison of nine blood tests and transient elastography for liver fibrosis in chronic hepatitis C: the ANRS HCEP-23 study J Hepatol 56 2012 55 62
66. L. Castera, J. Vergniol, J. Foucher Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C Gastroenterology 128 2005 343 350
67. M. Ziol, A. Handra-Luca, A. Kettaneh Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C Hepatology 41 2005 48 54
68. M. Lupsor, R. Badea, H. Stefanescu Analysis of histopathological changes that influence liver stiffness in chronic hepatitis C Results from a cohort of 324 patients J Gastrointest Liver Dis 17 2008 155 163
69. B. Coco, F. Oliveri, A.M. Maina Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases J Viral Hepat 14 2007 360 369
70. F. Oliveri, B. Coco, P. Ciccorossi Liver stiffness in the hepatitis B virus carrier: a non-invasive marker of liver disease influenced by the pattern of transaminases World J Gastroenterol 14 2008 6154 6162
71. P. Marcellin, M. Ziol, P. Bedossa Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B Liver Int 29 2009 242 247
72. H.L. Chan, G.L. Wong, P.C. Choi Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B J Viral Hepat 16 2009 36 44
73. N. Ganne-Carrie, M. Ziol, V. de Ledinghen Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases Hepatology 44 2006 1511 1517
74. A.A. Shaheen, A.F. Wan, R.P. Myers FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy Am J Gastroenterol 102 2007 2589 2600
75. J.A. Talwalkar, D.M. Kurtz, S.J. Schoenleber Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis Clin Gastroenterol Hepatol 5 2007 1214 1220
76. M. Friedrich-Rust, M.F. Ong, S. Martens Performance of transient elastography for the staging of liver fibrosis: a meta-analysis Gastroenterology 134 2008 960 974
77. E.A. Tsochatzis, K.S. Gurusamy, S. Ntaoula Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy J Hepatol 54 2011 650 659
78. M. Friedrich-Rust, J. Nierhoff, M. Lupsor Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis J Viral Hepat 19 2011 e212 e219
79. L. Huwart, C. Sempoux, E. Vicaut Magnetic resonance elastography for the noninvasive staging of liver fibrosis Gastroenterology 135 2008 32 40
80. S.M. Martinez, G. Crespo, M. Navasa Noninvasive assessment of liver fibrosis Hepatology 53 2011 325 335
81. G. Sebastiani, A. Vario, M. Guido Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C J Hepatol 44 2006 686 693
82. G. Sebastiani, P. Halfon, L. Castera SAFE biopsy: a validated method for large-scale staging of liver fibrosis in chronic hepatitis C Hepatology 49 2009 1821 1827
83. T. Poynard, P. Ingiliz, L. Elkrief Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers PLoS ONE 3 2008 e3857
84. J. Boursier, V. de Ledinghen, J.P. Zarski A new combination of blood test and Fibroscan for accurate non-invasive diagnosis of liver fibrosis stages in chronic hepatitis C Am J Gastroenterol 106 2011 1255 1263
85. T. Poynard, V. de Ledinghen, J.P. Zarski Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: a step toward the truth in the absence of a gold standard J Hepatol 56 2012 541 548
86. L. Castera, G. Sebastiani, B. Le Bail Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C J Hepatol 52 2010 191 198
87. J. Boursier, V. de Ledinghen, J.P. Zarski Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive Hepatology 55 2012 58 67
88. L. Castera, B. Le Bail, F. Roudot-Thoraval Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores J Hepatol 50 2009 59 68
89. G. Sebastiani, A. Vario, M. Guido Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B World J Gastroenterol 13 2007 525 531
90. G.L. Wong, V.W. Wong, P.C. Choi Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B Aliment Pharmacol Ther 31 2010 1095 1103
91. B.K. Kim, K.H. Han, J.Y. Park A novel liver stiffness measurement-based prediction model for cirrhosis in hepatitis B patients Liver Int 30 2010 1073 1081
92. H.J. Lee, Y.S. Seo, D.J. Kim Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B J Gastroenterol Hepatol 26 2011 987 995
93. S. Maimone, V. Calvaruso, M. Pleguezuelo An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers J Viral Hepat 16 2009 769 774
94. Y. Ngo, Y. Benhamou, V. Thibault An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load PLoS One 3 2008 e2573
95. L. Castera, P.H. Bernard, B. Le Bail Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers Aliment Pharmacol Ther 33 2011 455 465
96. Noninvasive methods for the evaluation of hepatic fibrosis/cirrhosis: an update http://www.has-sante.fr Accessed August 2008
97. L. Castera, P. Bedossa How to assess liver fibrosis in chronic hepatitis C: serum markers or transient elastography vs liver biopsy? Liver Int 31 Suppl 1 2011 13 17
98. C. Hezode, N. Forestier, G. Dusheiko Telaprevir and peginterferon with or without ribavirin for chronic HCV infection N Engl J Med 360 2009 1839 1850
99. P.Y. Kwo, E.J. Lawitz, J. McCone Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial Lancet 376 2010 705 716
100. E.J. Gane, S.K. Roberts, C.A. Stedman Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial Lancet 376 2010 1467 1475
101. A.S. Lok, D.F. Gardiner, E. Lawitz Preliminary study of two antiviral agents for hepatitis C genotype 1 N Engl J Med 366 2012 216 224
102. M. Vigano, S. Paggi, P. Lampertico Dual cut-off transient elastography to assess liver fibrosis in chronic hepatitis B: a cohort study with internal validation Aliment Pharmacol Ther 34 2011 353 362
103. T. Poynard, J. McHutchison, M. Manns Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C Gastroenterology 122 2002 1303 1313
104. Y. Shiratori, F. Imazeki, M. Moriyama Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy Ann Intern Med 132 2000 517 524
105. T.T. Chang, Y.F. Liaw, S.S. Wu Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B Hepatology 52 2010 886 893
106. S.J. Hadziyannis, N.C. Tassopoulos, E.J. Heathcote Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years Gastroenterology 131 2006 1743 1751
107. T. Poynard, F. Imbert-Bismut, V. Ratziu Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial J Viral Hepat 9 2002 128 133
108. T. Poynard, J. McHutchison, M. Manns Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin Hepatology 38 2003 481 492
109. R.J. Fontana, H.L. Bonkovsky, D. Naishadham Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis Clin Gastroenterol Hepatol 7 2009 219 226
110. E. Ogawa, N. Furusyo, K. Toyoda The longitudinal quantitative assessment by transient elastography of chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin Antiviral Res 83 2009 127 134
111. J. Vergniol, J. Foucher, L. Castera Changes of non-invasive markers and FibroScan values during HCV treatment J Viral Hepat 16 2009 132 140
112. S.M. Martinez, G. Fernandez-Varo, P. Gonzalez Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C Aliment Pharmacol Ther 33 2011 138 148
113. C. Hezode, L. Castera, F. Roudot-Thoraval Liver stiffness diminishes with antiviral response in chronic hepatitis C Aliment Pharmacol Ther 34 2011 656 663
114. T. Poynard, F. Zoulim, V. Ratziu Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection Am J Gastroenterol 100 2005 1970 1980
115. T. Poynard, Y. Ngo, P. Marcellin Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus J Viral Hepat 16 2009 203 213
116. G.L. Wong, V.W. Wong, P.C. Choi On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients Antivir Ther 16 2011 165 172
117. J. Fung, C.L. Lai, D.K. Wong Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study J Viral Hepat 18 2011 e200 e205
118. E. Ogawa, N. Furusyo, M. Murata Longitudinal assessment of liver stiffness by transient elastography for chronic hepatitis B patients treated with nucleoside analog Hepatol Res 41 2011 1178 1188
119. M. Enomoto, M. Mori, T. Ogawa Usefulness of transient elastography for assessment of liver fibrosis in chronic hepatitis B: regression of liver stiffness during entecavir therapy Hepatol Res 40 2010 853 861
120. K. Osakabe, N. Ichino, T. Nishikawa Reduction of liver stiffness by antiviral therapy in chronic hepatitis B J Gastroenterol 46 2011 1324 1334
121. S.G. Lim, S.W. Cho, Y.C. Lee Changes in liver stiffness measurement during antiviral therapy in patients with chronic hepatitis B Hepatogastroenterology 58 2011 539 545
122. J. Bruix, M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
123. G. Garcia-Tsao, S. Friedman, J. Iredale Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis Hepatology 51 2010 1445 1449
124. J. Foucher, E. Chanteloup, J. Vergniol Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study Gut 55 2006 403 408
125. J.A. Carrion, M. Navasa, J. Bosch Transient elastography for diagnosis of advanced fibrosis and portal hypertension in patients with hepatitis C recurrence after liver transplantation Liver Transpl 12 2006 1791 1798
126. F. Vizzutti, U. Arena, R.G. Romanelli Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis Hepatology 45 2007 1290 1297
127. C. Bureau, S. Metivier, J.M. Peron Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease Aliment Pharmacol Ther 27 2008 1261 1268
128. M. Lemoine, S. Katsahian, M. Ziol Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis Aliment Pharmacol Ther 28 2008 1102 1110
129. C. Ripoll, R. Groszmann, G. Garcia-Tsao Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis Gastroenterology 133 2007 481 488
130. C. Rigamonti, M.F. Donato, M. Fraquelli Transient elastography predicts fibrosis progression in patients with recurrent hepatitis C after liver transplantation Gut 57 2008 821 827
131. J.A. Carrion, F. Torres, G. Crespo Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation Hepatology 51 2010 23 34
132. L. Castera, M. Pinzani, J. Bosch Noninvasive evaluation of portal hypertension using transient elastography J Hepatol 56 2012 696 703
133. G. Sebastiani, D. Tempesta, G. Fattovich Prediction of oesophageal varices in hepatic cirrhosis by simple serum non-invasive markers: results of a multicenter, large-scale study J Hepatol 53 2010 630 638
134. R.J. Fontana, A.J. Sanyal, M.G. Ghany Factors that determine the development and progression of gastroesophageal varices in patients with chronic hepatitis C Gastroenterology 138 2010 2321 2331 e1-2
135. B.K. Kim, K.H. Han, J.Y. Park A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis Am J Gastroenterol 105 2010 1382 1390
136. B.K. Kim, Y. Kim do, K.H. Han Risk assessment of esophageal variceal bleeding in B-viral liver cirrhosis by a liver stiffness measurement-based model Am J Gastroenterol 106 2011 1654 1662 1730
137. M.A. Robic, B. Procopet, S. Metivier Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study J Hepatol 55 2011 1017 1024
138. J. Bosch Soft technique, hard end-points J Hepatol 55 2011 955 956
139. L. Castera Liver stiffness and hepatocellular carcinoma: liaisons dangereuses? Hepatology 49 2009 1793 1794
140. R. Masuzaki, R. Tateishi, H. Yoshida Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography Hepatology 49 2009 1954 1961
141. J. Fung, C.L. Lai, W.K. Seto Prognostic significance of liver stiffness for hepatocellular carcinoma and mortality in HBeAg-negative chronic hepatitis B J Viral Hepat 18 2011 738 744
142. K.S. Jung, S.U. Kim, S.H. Ahn Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan) Hepatology 53 2011 885 894
143. J. Vergniol, J. Foucher, E. Terrebonne Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C Gastroenterology 140 2011 1970 1979 e1-3
144. Y. Ngo, M. Munteanu, D. Messous A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C Clin Chem 52 2006 1887 1896
145. S. Naveau, G. Gaude, A. Asnacios Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease Hepatology 49 2009 97 105
146. M.J. Mayo, J. Parkes, B. Adams-Huet Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay Hepatology 48 2008 1549 1557
147. J. Parkes, P. Roderick, S. Harris Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease Gut 59 2010 1245 1251
148. D. Nunes, C. Fleming, G. Offner Noninvasive markers of liver fibrosis are highly predictive of liver-related death in a cohort of HCV-infected individuals with and without HIV infection Am J Gastroenterol 105 2010 1346 1353
149. M.G. Ghany, A.S. Lok, J.E. Everhart Predicting clinical and histologic outcomes based on standard laboratory tests in advanced chronic hepatitis C Gastroenterology 138 2010 136 146
150. R.J. Fontana, J.L. Dienstag, H.L. Bonkovsky Serum fibrosis markers are associated with liver disease progression in nonresponder patients with chronic hepatitis C Gut 59 2010 1401 1409
151. M. Pinzani Noninvasive methods for the assessment of liver fibrosis: a window open on the future? Hepatology 54 2011 1476 1477
152. L. Castera, J. Denis, G. Babany Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines? J Hepatol 46 2007 528 529
153. G. Sebastiani, A. Alberti Noninvasive fibrosis biomarkers reduce but not substitute the need for liver biopsy World J Gastroenterol 12 2006 3682 3694
154. M. Muller, J.L. Gennisson, T. Deffieux Quantitative viscoelasticity mapping of human liver using supersonic shear imaging: preliminary in vivo feasibility study Ultrasound Med Biol 35 2009 219 229
155. E. Bavu, J.L. Gennisson, M. Couade Noninvasive in vivo liver fibrosis evaluation using supersonic shear imaging: a clinical study on 113 hepatitis C virus patients Ultrasound Med Biol 37 2011 1361 1373
156. G.I. Nedredal, M. Yin, T. McKenzie Portal hypertension correlates with splenic stiffness as measured with MR elastography J Magn Reson Imaging 34 2011 79 87
157. T. Poynard, P. Lebray, P. Ingiliz Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest) BMC Gastroenterol 10 2010 40
158. D. Roulot, J.L. Costes, J.F. Buyck Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years Gut 60 2011 977 984
159. L. Castera Screening the general population for cirrhosis using transient elastography: finding a needle in a haystack? Gut 60 2011 883 884